SlideShare a Scribd company logo
ADVERSE DRUG REACTIONS
Nehal V. Trambadiya
Asst. professor
Department of Pharmacology
Smt. N. M. Padalia Pharmacy College
ADVERSE DRUG REACTION
Any noxious change which is
 Suspected to be due to a drug
 At doses normally used in man
 May requires treatment or decrease in dose or
 Caution in the future use of the same drug
ADVERSE DRUG EVENT (ADE)
Any untoward occurrence that may present during medical
treatment,
But
Does not necessarily have a causal relationship with the
treatment
 Incidence of ADR more
 Polypharmacy
 Elderly
 Children
 Patient with multiple diseases
 Pregnancy
 Malnourished
 Immunosuppression
 Drug Abusers and addicts
 Develop
 Immediately
or
• Prolonged medication
or
• After stopping.
GRADING OF SEVERITY OF ADVERSE DRUG REACTIONS :
 Minor : No therapy, antidote or prolongation of
hospitalization is required.
 Moderate: Requires change in drug therapy, specific
treatment or prolongs hospital stay.
 Severe: Potentially life-threatening, causes permanent
damage or requires intensive medical treatment.
 Lethal : Directly or indirectly contributes to death of the
patient.
CLASSIFICATIONS OF ADR
 A (Augmented)
 B (Bizarre)
 C (Continuous)
 D (Delayed)
 E (Ending Use)
 F (Failure of Efficacy)
Broadly
Type- A (Predictable)- Based on pharmacological properties
Type- B (Non-predictable) – Based on Immunological response
and genetic makeup of person
TYPE A- AUGMENTED
 These are based on the pharmacological properties of
the drug so can be predicted.
 They are common and account for 75% of ADRs
 Dose related and preventable mostly reversible.
Examples:-
 Anticoagulants (e.g., warfarin, heparin) – bleeding
 Anti-hypertensives (e.g.. α1-antagonists) – hypotension
 Anti-diabetics (e.g. insulin) - hypoglycemia
Predictable
TYPE B- BIZZARE OR UNPREDICTABLE
 Have no direct relationship to the dose of the drug or the
pharmacological mechanism of drug action.
 Develop on the basis of:
 Immunological reaction on a drug (Allergy)
 Genetic predisposition (Idiosyncratic reactions)
 More serious clinical outcomes with higher mortality and morbidity.
 Mostly require immediate withdrawal of the drug.
Un-predictable
TYPE C – CHRONIC (CONTINOUS) USE
 They are mostly associated with cumulative-long term
exposure
Example:-
Analgesic (NSAID)– interstitial nephritis, necrosis
Predictable
TYPE D – DELAYED
 They manifest themselves with significant delay
 Teratogenesis -Thalidomide – Phocomelia (flipper-like fore limbs)
 Mutagenesis/Cancerogenesis
Predictable
TYPE E – END OF USE
 Drug withdrawal syndromes and rebound
phenomenons
 Example – sudden withdrawal of long term therapy with -
blockers can induce rebound tachycardia and
hypertension
Predictable
PHARMACOVIGILANCE (DAUP)
The 'science and activities relating to the detection,
assessment, understanding and prevention of adverse
effects or any other drug related problems’
The information generated is useful in educating doctors and in
the official regulation of drug use.
It has an important role in rational use of medicines, as it
provides the basis for assessing safety of medicines.
Various activities involved in pharmacovigilance are:
 Postmarketing surveillance and other methods of ADR
monitoring such as voluntary reporting by doctors prescription
event monitoring.
 Dissemination of ADR data through 'drug alerts', 'medical
letters,' advisories sent to doctors by pharmaceuticals and
regulatory agencies.
 Changes in the labelling of medicines indicating
restrictions in use or statuary warnings, precautions,
or even withdrawal of the drug.
 The Uppsala Monitoring Centre (Sweden) is the international
collaborating centre.
 In India,
 National centre is located at Ghaziabad
 Peripheral Centres at Medical college levels and tertiary and above
hospitals
 Reports generated by doctors, paramedical staff--to peripheral
centre...National centre...Uppsala Monitoring Centre...Compilation of
data..analysis of data..causal association is confirmed..guidelines
issued regarding the safe use of medicine or (restricted use or
withdrawal from the market)
PREVENTION OF ADVERSE EFFECTS TO DRUGS
 Avoid inappropriate use of drugs .
 Appropriate drug administration (Rational Therapeutics)
 Dose
 Dosage form
 Duration
 Route
 Frequency
 Technique
 Ask for previous history of drug reactions and allergies
 Always suspect ADR when new symptom arises after initiation
of treatment.
 Ask for laboratory findings like serum creatinine etc.
Categorized into:
 Side effects-
 Secondary effects
 Toxic effects
 Intolerance
 Idiosyncrasy
 Drug allergy
 Photosensitivity
 Drug dependence
 Drug withdrawal reactions
 Teratogenicity
 Mutagenicity and Carcinogenicity
 Drug induced diseases (Iatrogenic disorders or Iatrogenicity)
Beware of – Iatrogenic, Idiosyncrasy, Idiopathic, Intolerance
SIDE EFFECTS
 Unwanted often unavoidable Pharmaco-dynamic effects.
 Occur at therapeutic doses.
 Predictable
Examples.
Benzodiazepines- Motor in coordination
H1 Anti-histaminics- Sedation
An effect may be therapeutic in one context but side effect in another context
 Depression of A-V conduction is the desired effect of digoxin in atrial
fibrillation, but the same may be undesirable when it is used for CHF.
Constipation by codeine is side effect but can be used as therapeutic effect in
patient with loose motions
SECONDARY EFFECTS
 Indirect consequences of a primary action of the drug.
 E.g. corticosteroids weaken host defence
mechanisms so that latent tuberculosis gets activated.
TOXIC EFFECTS (Poisonous effect)
It is the dose and duration which makes a poison....
 Over dose or prolonged use.
 The effects are predictable and dose related.
 The CNS, CVS, kidney, liver, lung, skin and bone marrow are
most commonly involved in drug toxicity.
 Toxicity may result from extension of the therapeutic
effect itself, e.g. complete A-V block by digoxin, bleeding
due to heparin.
 Poisoning: Poison is a substance which endangers life
by severely affecting one or more vital functions.
 Specific antidotes such as receptor antagonists,
chelating agents or specific antibodies are available for
few poisons.
 For others as well as for those poisons which have a
selective antagonist general supportive and
symptomatic treatment should be done.
 These measures are:
1. Resuscitation and maintenance of vital functions:
body temperature and blood glucose.
2.Termination of exposure (decontamination)
3. Prevention of absorption of ingested poisons.
4. Hastening elimination of the poison by inducing
diuresis or altering urinary pH
INTOLERANCE
 It is the appearance of characteristic toxic effects of
a drug in an individual at therapeutic doses
 It indicates a low threshold of the individual to the
action of a drug
 Example:- Only few doses of carbamazepine may
cause ataxia in some people
Un-Predictable
IDIOSYNCRASY
 It is genetically determined abnormal reactivity to a
chemical.
 The drug interacts with some unique feature of the individual,
not found in majority of subjects, and produces the
uncharacteristic reaction.
Example :-
 Chloramphenicol produces nondose-related
serious aplastic anaemia in rare individuals.
 Barbiturates cause excitement and mental confusion in some
individuals
Un-Predictable
DRUG ALLERGY
 It is also called drug hypersensitivity.
 It is an immunologically mediated reaction producing
stereotype symptoms which are unrelated to the
pharmacodynamic profile of the drug.
 It generally occur even with much smaller doses and
have a different time course of onset and duration.
Un-Predictable
 Allergic reactions occur only in a small proportion
of the population exposed to the drug .
 History of prior sensitization may or may not be
evident.
 The drug or its metabolite acts as antigen (AG) or
more commonly hapten (incomplete antigen) and
induce production of antibody (AB)/sensitized
lymphocytes.
PHOTOSENSITIVITY
 It is a cutaneous reaction resulting from drug induced
sensitization of the skin to UV radiation.
 The reactions are of two types:
a) Photo-toxic :-
a) Drug or its metabolite Accumulates in the skin,
b) absorbs light and undergoes a Photochemical reaction followed by
c) Photobiological reaction resulting in
d) Tissue damage (sunburn-like),
a) i.e. erythema, edema, blistering , hyper pigmentation,
The shorter wave lengths (290-320 nm, UVB) are responsible
(b) Photo-allergic:
Drug or its metabolites induce a cell mediated immune response
which on exposure to
Light of longer wave lengths (320-400 nm, UV -A)
Produces a papular or eczematous contact dermatitis like picture.
Drugs involved are sulfonamides, sulfonylureas, griseofulvin,
chloroquine, chlorpromazine
DRUG DEPENDENCE
 Use of drugs for personal satisfaction
 Higher priority than other basic needs, often in the face of
known risks to health.
Physical dependence It is an altered physiological state
produced by repeated administration of a drug which
necessitates the continued presence of the drug to maintain
physiological equilibrium.
 Discontinuation of the drug results in a characteristic
withdrawal (abstinence) syndrome.
 Drugs producing physical dependence are opioids, barbiturates
and other depressants including alcohol and benzodiazepines
 Drug abuse :
Refers to use of a drug by self medication in a manner and
amount that deviates from the approved medical and
social patterns in a given culture at a given time.
 Drug addiction
It is a pattern of compulsive drug use characterized by
overwhelming involvement with the use of a drug.
Procuring the drug and using it takes precedence over
other activities
 Drug habituation (Psychological dependence)
It denotes less intensive involvement with the drug, so that its
withdrawal produces only mild discomfort.
 Consumption of tea, coffee, tobacco, social drinking are
regarded habituating, physical dependence is absent
DRUG WITHDRAWAL REACTIONS
 Sudden interruption of therapy with certain other drugs results in
adverse consequences, mostly in the form of worsening of the
clinical condition for which the drug was being used
TERATOGENICITY (Teratos- Monster)
 Drug to cause foetal abnormalities when administered to the
pregnant mother.
 Drugs can affect the foetus at 3 stages-
(i) Fertilization and implantation-conception to
17 days-failure of pregnancy which often goes unnoticed.
(ii) Organogenesis-18 to 55 days of gestation most
vulnerable period, deformities are produced.
(iii) Growth and development-56 days onwards
developmental and functional abnormalities
can occur,
e.g. ACE inhibitors , Thalidomide, Warfarin,...............................
MUTAGENICITY AND CARCINOGENICITY
 Cause genetic defects and cancer respectively.
 Reactive intermediates which affect genes and may
cause structural changes in the chromosomes
 Even without interacting directly with DNA, certain
chemicals can promote malignant change in genetically
damaged cells, resulting in carcinogenesis.
 Examples- anticancer drugs, radioisotopes, estrogens,
tobacco...................................................
DRUG INDUCED DISEASES
 These are also called iatrogenic (physician induced)
diseases, and are functional disturbances (disease)
caused by drugs .
 Hepatitis by isoniazid and Rifampicin
 Peptic ulcer by salicylates and corticosteroids
 Retinal damage by chloroquine
MCQ ON ADR
 Which of the following drugs is teratogenic in nature
 Warfarin
 Ampicillin
 Paracetamol
 Adrenaline
Warfarin
MCQ ON ADR
 ADRs which are due to typical genetic make of
person are known as
 Side Effects
 Secondary Effects
 Iatrogenic disorders
 Idiosyncratic disorders
Iatrogenic disorders
MCQ ON ADR
 Withdrawal symptoms are common in which of the following
drugs
 Caffenine
 Paracetamol
 Opioids
 Cocaine
Opioids
MCQ ON ADR
 The most dangerous period regarding teratogenic effect is
 First trimester
 Second trimester
 Third trimester
 Early neonatal life
First Trimester
MCQ ON ADR
 International collaborating centre of Pharmacovigilance is
situated at
 United States of America
 Australia
 Sweden
 United Kingdom
Sweden
THANKS

More Related Content

What's hot

Adverse Drug Reactions (ADR’s)
Adverse Drug Reactions (ADR’s)Adverse Drug Reactions (ADR’s)
Adverse Drug Reactions (ADR’s)
Dikshakaushal8
 
Adverse drug reaction
Adverse drug reactionAdverse drug reaction
Adverse drug reaction
Sameen Rashid
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
Fariha Shikoh
 
Adverse drug reactions
Adverse drug reactionsAdverse drug reactions
Adverse drug reactions
government medical college nagpur
 
Adverse drug reaction and reporting
Adverse drug reaction and reportingAdverse drug reaction and reporting
Adverse drug reaction and reporting
Rupali Patil
 
Drug interactions
Drug interactionsDrug interactions
Drug interactions
Koppala RVS Chaitanya
 
Adr reporting ppt
Adr reporting pptAdr reporting ppt
Adr reporting ppt
RimaSingh14
 
Introduction to Adverse Drug Reactions
Introduction to Adverse Drug ReactionsIntroduction to Adverse Drug Reactions
Introduction to Adverse Drug ReactionsAbhik Seal
 
Adverse drug reactions
Adverse drug reactionsAdverse drug reactions
Adverse drug reactions
Dr. Ramesh Bhandari
 
ADVERSE DRUG REACTIONS
ADVERSE DRUG REACTIONSADVERSE DRUG REACTIONS
ADVERSE DRUG REACTIONS
Centro Escolar University-Makati
 
Adverse drug reactions
Adverse drug reactionsAdverse drug reactions
Adverse drug reactions
Satya Prakash Dixit
 
Adverse drug reactions
Adverse drug reactionsAdverse drug reactions
Adverse drug reactions
Jannatul Ferdoush
 
Adverse drug reactions
Adverse drug reactionsAdverse drug reactions
Adverse drug reactions
HariKrishnan835
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
PharmacologyMGM
 
Adverse drug reaction
Adverse   drug  reactionAdverse   drug  reaction
Adverse drug reaction
Viraj Shinde
 
Essential drug concept and rational use of medicines
Essential drug concept and rational use of medicinesEssential drug concept and rational use of medicines
Essential drug concept and rational use of medicines
Pravin Prasad
 
Drug interaction final
Drug interaction finalDrug interaction final
Drug interaction final
Pabitra Thapa
 
drug interactions
drug interactionsdrug interactions
drug interactions
Rahul Bhati
 
Pharmacovigilance and Method of ADR reporting
Pharmacovigilance and Method of ADR reportingPharmacovigilance and Method of ADR reporting
Pharmacovigilance and Method of ADR reporting
SMS MEDICAL COLLEGE
 
Ashutosh pharmacovigilance
Ashutosh pharmacovigilance Ashutosh pharmacovigilance
Ashutosh pharmacovigilance ASHUTOSH MISHRA
 

What's hot (20)

Adverse Drug Reactions (ADR’s)
Adverse Drug Reactions (ADR’s)Adverse Drug Reactions (ADR’s)
Adverse Drug Reactions (ADR’s)
 
Adverse drug reaction
Adverse drug reactionAdverse drug reaction
Adverse drug reaction
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
 
Adverse drug reactions
Adverse drug reactionsAdverse drug reactions
Adverse drug reactions
 
Adverse drug reaction and reporting
Adverse drug reaction and reportingAdverse drug reaction and reporting
Adverse drug reaction and reporting
 
Drug interactions
Drug interactionsDrug interactions
Drug interactions
 
Adr reporting ppt
Adr reporting pptAdr reporting ppt
Adr reporting ppt
 
Introduction to Adverse Drug Reactions
Introduction to Adverse Drug ReactionsIntroduction to Adverse Drug Reactions
Introduction to Adverse Drug Reactions
 
Adverse drug reactions
Adverse drug reactionsAdverse drug reactions
Adverse drug reactions
 
ADVERSE DRUG REACTIONS
ADVERSE DRUG REACTIONSADVERSE DRUG REACTIONS
ADVERSE DRUG REACTIONS
 
Adverse drug reactions
Adverse drug reactionsAdverse drug reactions
Adverse drug reactions
 
Adverse drug reactions
Adverse drug reactionsAdverse drug reactions
Adverse drug reactions
 
Adverse drug reactions
Adverse drug reactionsAdverse drug reactions
Adverse drug reactions
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
 
Adverse drug reaction
Adverse   drug  reactionAdverse   drug  reaction
Adverse drug reaction
 
Essential drug concept and rational use of medicines
Essential drug concept and rational use of medicinesEssential drug concept and rational use of medicines
Essential drug concept and rational use of medicines
 
Drug interaction final
Drug interaction finalDrug interaction final
Drug interaction final
 
drug interactions
drug interactionsdrug interactions
drug interactions
 
Pharmacovigilance and Method of ADR reporting
Pharmacovigilance and Method of ADR reportingPharmacovigilance and Method of ADR reporting
Pharmacovigilance and Method of ADR reporting
 
Ashutosh pharmacovigilance
Ashutosh pharmacovigilance Ashutosh pharmacovigilance
Ashutosh pharmacovigilance
 

Similar to Adverse Drug Reaction - Pharmacology

ADR.ppt arverse drug reactions power pt
ADR.ppt  arverse drug reactions power ptADR.ppt  arverse drug reactions power pt
ADR.ppt arverse drug reactions power pt
Suma Lakavath
 
ADR.ppt pharmacilogy ppt of adverse drug reaction
ADR.ppt pharmacilogy ppt of adverse drug reactionADR.ppt pharmacilogy ppt of adverse drug reaction
ADR.ppt pharmacilogy ppt of adverse drug reaction
Suma Lakavath
 
Adverse Drug reactions and its types with examples
Adverse Drug reactions and its types with examplesAdverse Drug reactions and its types with examples
Adverse Drug reactions and its types with examples
Sushil Mahato(Pharm-D)
 
Adverse Reactions.ppt
Adverse Reactions.pptAdverse Reactions.ppt
Adverse Reactions.ppt
KeyaArere
 
Adverse Reactions.ppt
Adverse Reactions.pptAdverse Reactions.ppt
Adverse Reactions.ppt
Brigidkiplagat
 
Carcinogenesis
Carcinogenesis Carcinogenesis
Carcinogenesis
WHO
 
5.ppt
5.ppt5.ppt
ADRs.ppt
ADRs.pptADRs.ppt
ADRs.ppt
ssuserf14ecf
 
Adverse drug reaction ,pharmacy practice
Adverse drug reaction ,pharmacy practiceAdverse drug reaction ,pharmacy practice
Adverse drug reaction ,pharmacy practice
Deepali69
 
ADR-RDP-2023.pdf
ADR-RDP-2023.pdfADR-RDP-2023.pdf
ADR-RDP-2023.pdf
rishi2789
 
Adverse Drug Reaction
Adverse Drug ReactionAdverse Drug Reaction
Adverse Drug Reaction
Lok Raj Bhandari
 
Adverese drug effects
Adverese drug effectsAdverese drug effects
Adverese drug effects
Chintan Doshi
 
ADR Class for Nurses.pptx
ADR Class for Nurses.pptxADR Class for Nurses.pptx
ADR Class for Nurses.pptx
Dr.Irfan shaikh
 
ADR by Mukesh Jaiswal & Somya Verma
ADR by Mukesh Jaiswal & Somya VermaADR by Mukesh Jaiswal & Somya Verma
ADR by Mukesh Jaiswal & Somya Verma
Mukesh Jaiswal
 
Adverse Drug Reaction and its reporting
Adverse Drug Reaction and its reporting Adverse Drug Reaction and its reporting
Adverse Drug Reaction and its reporting
MangeshBansod2
 
adr ppt (2).ppt
adr ppt (2).pptadr ppt (2).ppt
adr ppt (2).ppt
sumiaru
 
Adverse drug reaction
Adverse drug reactionAdverse drug reaction
Adverse drug reaction
Dr Bikash Ranjan Meher
 
OVERVIEW OF ADR.pptx
OVERVIEW OF ADR.pptxOVERVIEW OF ADR.pptx
OVERVIEW OF ADR.pptx
Dr. Debjyoti Halder
 

Similar to Adverse Drug Reaction - Pharmacology (20)

ADR.ppt arverse drug reactions power pt
ADR.ppt  arverse drug reactions power ptADR.ppt  arverse drug reactions power pt
ADR.ppt arverse drug reactions power pt
 
ADR.ppt pharmacilogy ppt of adverse drug reaction
ADR.ppt pharmacilogy ppt of adverse drug reactionADR.ppt pharmacilogy ppt of adverse drug reaction
ADR.ppt pharmacilogy ppt of adverse drug reaction
 
Adverse Drug reactions and its types with examples
Adverse Drug reactions and its types with examplesAdverse Drug reactions and its types with examples
Adverse Drug reactions and its types with examples
 
Adverse Reactions.ppt
Adverse Reactions.pptAdverse Reactions.ppt
Adverse Reactions.ppt
 
Adverse Reactions.ppt
Adverse Reactions.pptAdverse Reactions.ppt
Adverse Reactions.ppt
 
HAROON ADR.ppt
HAROON ADR.pptHAROON ADR.ppt
HAROON ADR.ppt
 
Carcinogenesis
Carcinogenesis Carcinogenesis
Carcinogenesis
 
5.ppt
5.ppt5.ppt
5.ppt
 
ADRs.ppt
ADRs.pptADRs.ppt
ADRs.ppt
 
ADRs.pptx
ADRs.pptxADRs.pptx
ADRs.pptx
 
Adverse drug reaction ,pharmacy practice
Adverse drug reaction ,pharmacy practiceAdverse drug reaction ,pharmacy practice
Adverse drug reaction ,pharmacy practice
 
ADR-RDP-2023.pdf
ADR-RDP-2023.pdfADR-RDP-2023.pdf
ADR-RDP-2023.pdf
 
Adverse Drug Reaction
Adverse Drug ReactionAdverse Drug Reaction
Adverse Drug Reaction
 
Adverese drug effects
Adverese drug effectsAdverese drug effects
Adverese drug effects
 
ADR Class for Nurses.pptx
ADR Class for Nurses.pptxADR Class for Nurses.pptx
ADR Class for Nurses.pptx
 
ADR by Mukesh Jaiswal & Somya Verma
ADR by Mukesh Jaiswal & Somya VermaADR by Mukesh Jaiswal & Somya Verma
ADR by Mukesh Jaiswal & Somya Verma
 
Adverse Drug Reaction and its reporting
Adverse Drug Reaction and its reporting Adverse Drug Reaction and its reporting
Adverse Drug Reaction and its reporting
 
adr ppt (2).ppt
adr ppt (2).pptadr ppt (2).ppt
adr ppt (2).ppt
 
Adverse drug reaction
Adverse drug reactionAdverse drug reaction
Adverse drug reaction
 
OVERVIEW OF ADR.pptx
OVERVIEW OF ADR.pptxOVERVIEW OF ADR.pptx
OVERVIEW OF ADR.pptx
 

More from AdarshPatel73

Prevention of cruelty of animals act - Pharma Jury
Prevention of cruelty of animals act - Pharma JuryPrevention of cruelty of animals act - Pharma Jury
Prevention of cruelty of animals act - Pharma Jury
AdarshPatel73
 
Poison act - Pharma Jury
Poison act - Pharma JuryPoison act - Pharma Jury
Poison act - Pharma Jury
AdarshPatel73
 
Narcotics and psychotropic act - Pharma Jury
Narcotics and psychotropic act - Pharma JuryNarcotics and psychotropic act - Pharma Jury
Narcotics and psychotropic act - Pharma Jury
AdarshPatel73
 
M and TP act - Pharma Jury
M and TP act - Pharma JuryM and TP act - Pharma Jury
M and TP act - Pharma Jury
AdarshPatel73
 
Pharmacy act - Pharma Jury
 Pharmacy act - Pharma Jury Pharmacy act - Pharma Jury
Pharmacy act - Pharma Jury
AdarshPatel73
 
Parasympatholytics - Pharmacology
Parasympatholytics - PharmacologyParasympatholytics - Pharmacology
Parasympatholytics - Pharmacology
AdarshPatel73
 
Basic concepts - Pharmacology
Basic concepts - PharmacologyBasic concepts - Pharmacology
Basic concepts - Pharmacology
AdarshPatel73
 
Parkinson's - Pharmacology
Parkinson's - PharmacologyParkinson's - Pharmacology
Parkinson's - Pharmacology
AdarshPatel73
 
Sympathomimetic System- Pharmacology
Sympathomimetic System- PharmacologySympathomimetic System- Pharmacology
Sympathomimetic System- Pharmacology
AdarshPatel73
 
Neurohumoral Transmission in CNS - Pharmacology
Neurohumoral Transmission in CNS  - PharmacologyNeurohumoral Transmission in CNS  - Pharmacology
Neurohumoral Transmission in CNS - Pharmacology
AdarshPatel73
 
Cholinergic System - Pharmacology
Cholinergic System - PharmacologyCholinergic System - Pharmacology
Cholinergic System - Pharmacology
AdarshPatel73
 
Alcohol - Pharmacology
Alcohol - PharmacologyAlcohol - Pharmacology
Alcohol - Pharmacology
AdarshPatel73
 
Micromeritics 1 - Physical Pharmacy
Micromeritics 1 - Physical PharmacyMicromeritics 1 - Physical Pharmacy
Micromeritics 1 - Physical Pharmacy
AdarshPatel73
 
Suspension - Physical Pharmacy
Suspension - Physical PharmacySuspension - Physical Pharmacy
Suspension - Physical Pharmacy
AdarshPatel73
 
Emulsion - Physical Pharmacy
Emulsion - Physical PharmacyEmulsion - Physical Pharmacy
Emulsion - Physical Pharmacy
AdarshPatel73
 
Colloids - Physical Pharmacy
 Colloids - Physical Pharmacy Colloids - Physical Pharmacy
Colloids - Physical Pharmacy
AdarshPatel73
 

More from AdarshPatel73 (16)

Prevention of cruelty of animals act - Pharma Jury
Prevention of cruelty of animals act - Pharma JuryPrevention of cruelty of animals act - Pharma Jury
Prevention of cruelty of animals act - Pharma Jury
 
Poison act - Pharma Jury
Poison act - Pharma JuryPoison act - Pharma Jury
Poison act - Pharma Jury
 
Narcotics and psychotropic act - Pharma Jury
Narcotics and psychotropic act - Pharma JuryNarcotics and psychotropic act - Pharma Jury
Narcotics and psychotropic act - Pharma Jury
 
M and TP act - Pharma Jury
M and TP act - Pharma JuryM and TP act - Pharma Jury
M and TP act - Pharma Jury
 
Pharmacy act - Pharma Jury
 Pharmacy act - Pharma Jury Pharmacy act - Pharma Jury
Pharmacy act - Pharma Jury
 
Parasympatholytics - Pharmacology
Parasympatholytics - PharmacologyParasympatholytics - Pharmacology
Parasympatholytics - Pharmacology
 
Basic concepts - Pharmacology
Basic concepts - PharmacologyBasic concepts - Pharmacology
Basic concepts - Pharmacology
 
Parkinson's - Pharmacology
Parkinson's - PharmacologyParkinson's - Pharmacology
Parkinson's - Pharmacology
 
Sympathomimetic System- Pharmacology
Sympathomimetic System- PharmacologySympathomimetic System- Pharmacology
Sympathomimetic System- Pharmacology
 
Neurohumoral Transmission in CNS - Pharmacology
Neurohumoral Transmission in CNS  - PharmacologyNeurohumoral Transmission in CNS  - Pharmacology
Neurohumoral Transmission in CNS - Pharmacology
 
Cholinergic System - Pharmacology
Cholinergic System - PharmacologyCholinergic System - Pharmacology
Cholinergic System - Pharmacology
 
Alcohol - Pharmacology
Alcohol - PharmacologyAlcohol - Pharmacology
Alcohol - Pharmacology
 
Micromeritics 1 - Physical Pharmacy
Micromeritics 1 - Physical PharmacyMicromeritics 1 - Physical Pharmacy
Micromeritics 1 - Physical Pharmacy
 
Suspension - Physical Pharmacy
Suspension - Physical PharmacySuspension - Physical Pharmacy
Suspension - Physical Pharmacy
 
Emulsion - Physical Pharmacy
Emulsion - Physical PharmacyEmulsion - Physical Pharmacy
Emulsion - Physical Pharmacy
 
Colloids - Physical Pharmacy
 Colloids - Physical Pharmacy Colloids - Physical Pharmacy
Colloids - Physical Pharmacy
 

Recently uploaded

The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
Catherine Liao
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
Catherine Liao
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
DrSathishMS1
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
jval Landero
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Dr KHALID B.M
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 

Recently uploaded (20)

The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 

Adverse Drug Reaction - Pharmacology

  • 1. ADVERSE DRUG REACTIONS Nehal V. Trambadiya Asst. professor Department of Pharmacology Smt. N. M. Padalia Pharmacy College
  • 2. ADVERSE DRUG REACTION Any noxious change which is  Suspected to be due to a drug  At doses normally used in man  May requires treatment or decrease in dose or  Caution in the future use of the same drug
  • 3. ADVERSE DRUG EVENT (ADE) Any untoward occurrence that may present during medical treatment, But Does not necessarily have a causal relationship with the treatment
  • 4.  Incidence of ADR more  Polypharmacy  Elderly  Children  Patient with multiple diseases  Pregnancy  Malnourished  Immunosuppression  Drug Abusers and addicts  Develop  Immediately or • Prolonged medication or • After stopping.
  • 5. GRADING OF SEVERITY OF ADVERSE DRUG REACTIONS :  Minor : No therapy, antidote or prolongation of hospitalization is required.  Moderate: Requires change in drug therapy, specific treatment or prolongs hospital stay.  Severe: Potentially life-threatening, causes permanent damage or requires intensive medical treatment.  Lethal : Directly or indirectly contributes to death of the patient.
  • 6. CLASSIFICATIONS OF ADR  A (Augmented)  B (Bizarre)  C (Continuous)  D (Delayed)  E (Ending Use)  F (Failure of Efficacy) Broadly Type- A (Predictable)- Based on pharmacological properties Type- B (Non-predictable) – Based on Immunological response and genetic makeup of person
  • 7. TYPE A- AUGMENTED  These are based on the pharmacological properties of the drug so can be predicted.  They are common and account for 75% of ADRs  Dose related and preventable mostly reversible. Examples:-  Anticoagulants (e.g., warfarin, heparin) – bleeding  Anti-hypertensives (e.g.. α1-antagonists) – hypotension  Anti-diabetics (e.g. insulin) - hypoglycemia Predictable
  • 8. TYPE B- BIZZARE OR UNPREDICTABLE  Have no direct relationship to the dose of the drug or the pharmacological mechanism of drug action.  Develop on the basis of:  Immunological reaction on a drug (Allergy)  Genetic predisposition (Idiosyncratic reactions)  More serious clinical outcomes with higher mortality and morbidity.  Mostly require immediate withdrawal of the drug. Un-predictable
  • 9. TYPE C – CHRONIC (CONTINOUS) USE  They are mostly associated with cumulative-long term exposure Example:- Analgesic (NSAID)– interstitial nephritis, necrosis Predictable
  • 10. TYPE D – DELAYED  They manifest themselves with significant delay  Teratogenesis -Thalidomide – Phocomelia (flipper-like fore limbs)  Mutagenesis/Cancerogenesis Predictable
  • 11. TYPE E – END OF USE  Drug withdrawal syndromes and rebound phenomenons  Example – sudden withdrawal of long term therapy with - blockers can induce rebound tachycardia and hypertension Predictable
  • 12. PHARMACOVIGILANCE (DAUP) The 'science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug related problems’ The information generated is useful in educating doctors and in the official regulation of drug use. It has an important role in rational use of medicines, as it provides the basis for assessing safety of medicines.
  • 13. Various activities involved in pharmacovigilance are:  Postmarketing surveillance and other methods of ADR monitoring such as voluntary reporting by doctors prescription event monitoring.  Dissemination of ADR data through 'drug alerts', 'medical letters,' advisories sent to doctors by pharmaceuticals and regulatory agencies.  Changes in the labelling of medicines indicating restrictions in use or statuary warnings, precautions, or even withdrawal of the drug.
  • 14.  The Uppsala Monitoring Centre (Sweden) is the international collaborating centre.  In India,  National centre is located at Ghaziabad  Peripheral Centres at Medical college levels and tertiary and above hospitals  Reports generated by doctors, paramedical staff--to peripheral centre...National centre...Uppsala Monitoring Centre...Compilation of data..analysis of data..causal association is confirmed..guidelines issued regarding the safe use of medicine or (restricted use or withdrawal from the market)
  • 15. PREVENTION OF ADVERSE EFFECTS TO DRUGS  Avoid inappropriate use of drugs .  Appropriate drug administration (Rational Therapeutics)  Dose  Dosage form  Duration  Route  Frequency  Technique  Ask for previous history of drug reactions and allergies  Always suspect ADR when new symptom arises after initiation of treatment.  Ask for laboratory findings like serum creatinine etc.
  • 16. Categorized into:  Side effects-  Secondary effects  Toxic effects  Intolerance  Idiosyncrasy  Drug allergy  Photosensitivity  Drug dependence  Drug withdrawal reactions  Teratogenicity  Mutagenicity and Carcinogenicity  Drug induced diseases (Iatrogenic disorders or Iatrogenicity) Beware of – Iatrogenic, Idiosyncrasy, Idiopathic, Intolerance
  • 17. SIDE EFFECTS  Unwanted often unavoidable Pharmaco-dynamic effects.  Occur at therapeutic doses.  Predictable Examples. Benzodiazepines- Motor in coordination H1 Anti-histaminics- Sedation An effect may be therapeutic in one context but side effect in another context  Depression of A-V conduction is the desired effect of digoxin in atrial fibrillation, but the same may be undesirable when it is used for CHF. Constipation by codeine is side effect but can be used as therapeutic effect in patient with loose motions
  • 18. SECONDARY EFFECTS  Indirect consequences of a primary action of the drug.  E.g. corticosteroids weaken host defence mechanisms so that latent tuberculosis gets activated.
  • 19. TOXIC EFFECTS (Poisonous effect) It is the dose and duration which makes a poison....  Over dose or prolonged use.  The effects are predictable and dose related.  The CNS, CVS, kidney, liver, lung, skin and bone marrow are most commonly involved in drug toxicity.
  • 20.  Toxicity may result from extension of the therapeutic effect itself, e.g. complete A-V block by digoxin, bleeding due to heparin.  Poisoning: Poison is a substance which endangers life by severely affecting one or more vital functions.
  • 21.  Specific antidotes such as receptor antagonists, chelating agents or specific antibodies are available for few poisons.  For others as well as for those poisons which have a selective antagonist general supportive and symptomatic treatment should be done.  These measures are: 1. Resuscitation and maintenance of vital functions: body temperature and blood glucose. 2.Termination of exposure (decontamination) 3. Prevention of absorption of ingested poisons. 4. Hastening elimination of the poison by inducing diuresis or altering urinary pH
  • 22. INTOLERANCE  It is the appearance of characteristic toxic effects of a drug in an individual at therapeutic doses  It indicates a low threshold of the individual to the action of a drug  Example:- Only few doses of carbamazepine may cause ataxia in some people Un-Predictable
  • 23. IDIOSYNCRASY  It is genetically determined abnormal reactivity to a chemical.  The drug interacts with some unique feature of the individual, not found in majority of subjects, and produces the uncharacteristic reaction. Example :-  Chloramphenicol produces nondose-related serious aplastic anaemia in rare individuals.  Barbiturates cause excitement and mental confusion in some individuals Un-Predictable
  • 24. DRUG ALLERGY  It is also called drug hypersensitivity.  It is an immunologically mediated reaction producing stereotype symptoms which are unrelated to the pharmacodynamic profile of the drug.  It generally occur even with much smaller doses and have a different time course of onset and duration. Un-Predictable
  • 25.  Allergic reactions occur only in a small proportion of the population exposed to the drug .  History of prior sensitization may or may not be evident.  The drug or its metabolite acts as antigen (AG) or more commonly hapten (incomplete antigen) and induce production of antibody (AB)/sensitized lymphocytes.
  • 26. PHOTOSENSITIVITY  It is a cutaneous reaction resulting from drug induced sensitization of the skin to UV radiation.  The reactions are of two types: a) Photo-toxic :- a) Drug or its metabolite Accumulates in the skin, b) absorbs light and undergoes a Photochemical reaction followed by c) Photobiological reaction resulting in d) Tissue damage (sunburn-like), a) i.e. erythema, edema, blistering , hyper pigmentation, The shorter wave lengths (290-320 nm, UVB) are responsible
  • 27. (b) Photo-allergic: Drug or its metabolites induce a cell mediated immune response which on exposure to Light of longer wave lengths (320-400 nm, UV -A) Produces a papular or eczematous contact dermatitis like picture. Drugs involved are sulfonamides, sulfonylureas, griseofulvin, chloroquine, chlorpromazine
  • 28. DRUG DEPENDENCE  Use of drugs for personal satisfaction  Higher priority than other basic needs, often in the face of known risks to health. Physical dependence It is an altered physiological state produced by repeated administration of a drug which necessitates the continued presence of the drug to maintain physiological equilibrium.  Discontinuation of the drug results in a characteristic withdrawal (abstinence) syndrome.  Drugs producing physical dependence are opioids, barbiturates and other depressants including alcohol and benzodiazepines
  • 29.  Drug abuse : Refers to use of a drug by self medication in a manner and amount that deviates from the approved medical and social patterns in a given culture at a given time.  Drug addiction It is a pattern of compulsive drug use characterized by overwhelming involvement with the use of a drug. Procuring the drug and using it takes precedence over other activities
  • 30.  Drug habituation (Psychological dependence) It denotes less intensive involvement with the drug, so that its withdrawal produces only mild discomfort.  Consumption of tea, coffee, tobacco, social drinking are regarded habituating, physical dependence is absent
  • 31. DRUG WITHDRAWAL REACTIONS  Sudden interruption of therapy with certain other drugs results in adverse consequences, mostly in the form of worsening of the clinical condition for which the drug was being used
  • 32. TERATOGENICITY (Teratos- Monster)  Drug to cause foetal abnormalities when administered to the pregnant mother.  Drugs can affect the foetus at 3 stages- (i) Fertilization and implantation-conception to 17 days-failure of pregnancy which often goes unnoticed. (ii) Organogenesis-18 to 55 days of gestation most vulnerable period, deformities are produced. (iii) Growth and development-56 days onwards developmental and functional abnormalities can occur, e.g. ACE inhibitors , Thalidomide, Warfarin,...............................
  • 33. MUTAGENICITY AND CARCINOGENICITY  Cause genetic defects and cancer respectively.  Reactive intermediates which affect genes and may cause structural changes in the chromosomes  Even without interacting directly with DNA, certain chemicals can promote malignant change in genetically damaged cells, resulting in carcinogenesis.  Examples- anticancer drugs, radioisotopes, estrogens, tobacco...................................................
  • 34. DRUG INDUCED DISEASES  These are also called iatrogenic (physician induced) diseases, and are functional disturbances (disease) caused by drugs .  Hepatitis by isoniazid and Rifampicin  Peptic ulcer by salicylates and corticosteroids  Retinal damage by chloroquine
  • 35. MCQ ON ADR  Which of the following drugs is teratogenic in nature  Warfarin  Ampicillin  Paracetamol  Adrenaline Warfarin
  • 36. MCQ ON ADR  ADRs which are due to typical genetic make of person are known as  Side Effects  Secondary Effects  Iatrogenic disorders  Idiosyncratic disorders Iatrogenic disorders
  • 37. MCQ ON ADR  Withdrawal symptoms are common in which of the following drugs  Caffenine  Paracetamol  Opioids  Cocaine Opioids
  • 38. MCQ ON ADR  The most dangerous period regarding teratogenic effect is  First trimester  Second trimester  Third trimester  Early neonatal life First Trimester
  • 39. MCQ ON ADR  International collaborating centre of Pharmacovigilance is situated at  United States of America  Australia  Sweden  United Kingdom Sweden